Alvesco FDA Approval History
FDA Approved: Yes (First approved January 10, 2008)
Brand name: Alvesco
Generic name: ciclesonide
Dosage form: Inhalation Aerosol
Treatment for: Asthma
Alvesco (ciclesonide) is an inhaled corticosteroid indicated for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.
Development timeline for Alvesco
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.